title: Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response.
authors.affiliation: Institute of Cellular Medicine, Musculoskeletal Research Group, Newcastle University.
authors.forename: Catherine
authors.initials: C
authors.lastname: Potter
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Gibbons
authors.forename: John D
authors.initials: JD
authors.lastname: Bowes
authors.forename: Heather J
authors.initials: HJ
authors.lastname: Cordell
authors.forename: Kimme
authors.initials: K
authors.lastname: Hyrich
authors.forename: John D
authors.initials: JD
authors.lastname: Isaacs
authors.forename: Ann W
authors.initials: AW
authors.lastname: Morgan
authors.forename: Anthony G
authors.initials: AG
authors.lastname: Wilson
authors.forename: Anne
authors.initials: A
authors.lastname: Barton
mesh_terms: D051722:ADAM Proteins / Q000235:genetics*; D000072198:ADAM17 Protein; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000235:genetics*; D002874:Chromosome Mapping; D015331:Cohort Studies; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D008957:Models, Genetic; D015999:Multivariate Analysis; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000235:genetics*; D012044:Regression Analysis; D015203:Reproducibility of Results; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism*
chemical_list: D047889:Receptors, Tumor Necrosis Factor, Type II; D014409:Tumor Necrosis Factor-alpha; D051722:ADAM Proteins; D000072198:ADAM17 Protein; C000606462:ADAM17 protein, human